[December 28, 2016]

Genexine to Present at the 35th J.P. Morgan Healthcare Conference

Genexine Inc. (KOSDAQ: 095700), a clinical stage biotechnology company developing innovative biologics focused on immuno-oncology and metabolic/autoimmune diseases, today announced that Dr. H. Michael Keyoung, CEO and President of Genexine, will present at the J.P. Morgan 35^th Annual Healthcare Conference Emerging Markets Track on January 11th at the Westin St. Francis Hotel, San Francisco. The J.P. Morgan Healthcare Conference is one of the healthcare industry's biggest events of the year and it brings thousands of investors and executives from around the world to San Francisco.

<>Event: The 35^th Annual J.P. Morgan Healthcare Conference Emerging Market Track

About Genexine

Genexine, Inc., listed on KOSDAQ (095700-KQ) since 2009, is a clinical stage biotherapeutics company focused on immuno-oncology and metabolic/autoimmune diseases. Genexine has robust pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA vaccine technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH-hyFc) for both adult and pediatric GHD, currently in multinational phase II trials. GX-188E therapeutic DNA vaccine for HPV-associated diseases is in Phase II in Europe and Korea for Cervical Intraepithelial Neoplasia II/III and plans to enter into Phase 1b/2a trial in cervical cancer with GX-188E in combination Keytruda (anti- PD-1 therapy) of Merck (also known as MSD) 1H of 2017. Currently Genexine is running over 8 clinical trials from Phase I to Phase IIb in Europe and Asia. In addition to Merck (MSD) collaboration, Genexine has strategic partnerships with leading Asian companies such as Shanghai Fosun Pharma, Tasly Pharma, Kalbe Pharma (largest healthcare Indonesian company), and Korean big Pharma companies such as Green Cross and Yuhan. Founded in 1999, Genexine has over 150 employees and half of them are scientists with MSc or Ph.D. Genexine is located in Pangyo Techno Valley near Seoul, Korea with a branch office in New York.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161228005157/en/

[ Back To TMCnet.com's Homepage ]